Q4 2024 Management View CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

Hennes & Mauritz AB sales growth continued to disappoint even as Chief Executive Officer Daniel Erver’s turnaround strategy ...

German retail sales rose in 2024, but growth should be more modest this year due to the high level of uncertainty, according ...

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

Shares in LVMH fell in early Frankfurt trading on Wednesday, as sales growth posted by the luxury goods group failed to ...

TVS 2W and 3W sales in Jan 2025 showed off strong performance in domestic markets while 2W exports and 3W exports suffered ...

General Dynamics faces challenges in the aerospace and submarine segments, impacting performance, but growth expected, ...

Eaton Corporation (NYSE:ETN) shares are trading lower on Friday after the company reported fourth-quarter 2024 results.

CFO Rick Dierker reported a 19% increase in EPS for Q4 2024, alongside 3.5% reported sales growth. He emphasized momentum in international markets, which grew 9% year-over-year, and highlighted $1.16 ...

"With investors highly tuned into how AI spend will represent real revenue for big tech, Apple's results have ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...